​

OUR MISSION

To be a world leader in liquid biopsy and artificial intelligence for early detection of cancer and other diseases.

ClinSpec Dx™ are an award winning team, dedicated to translating this novel technology into the clinic. 

​

Founded in 2016, ClinSpec Dx™ are the spinout company from the University of Strathclyde based upon world leading research.

​

The team have secured over £2m of funding and continue to advance towards the clinic.

OUR HISTORY

WE BELIEVE THAT

EVERY DAY COUNTS

For patients.png

FOR PATIENTS

For clinicians.png

FOR CLINICIANS

For health services.png

FOR HEALTH SERVICES

OUR PLAN

ClinSpec Dx™ are currently raising their second round of funding.

​

For more information, please contact us or see our page for investors. 

For Investors ⌲
Contact Us ⌲

OUR VALUES

OUR VALUES

Innovation

Team value.png

Team

Commitment value.png

Commitment

Ambition value.png

Ambition

Integrity value.png

Integrity

Problem sloving value.png

Problem solving